AKT1 and cancer: The top five pathways were identified as cancer (hsa05200, 54.69%), PI3K-Akt signaling pathway (hsa04151, 37.5%), proteoglycans in cancer (hsa05205, 32.81%), microRNAs in cancer (hsa05206, 29.69%), and endocrine resistance (hsa01522, 25%).